Regeneration and bioengineering of the kidney: Current status and future challenges

Marcus Salvatori, Andrea Peloso, Ravi Katari, Giuseppe Orlando

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.

Original languageEnglish
Article number379
JournalCurrent Urology Reports
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Bioengineering
Regeneration
Kidney
Artificial Organs
Regenerative Medicine
Renal Replacement Therapy
Homologous Transplantation
Tissue Engineering
Cell- and Tissue-Based Therapy
Chronic Renal Insufficiency
Immunosuppression
Allografts
Tissue Donors
Technology
Morbidity
Costs and Cost Analysis
Therapeutics

Keywords

  • ARFAcuteRenalFailure
  • BAKBio-ArtificialKidney
  • BMDCBone Marrow-Derived Stem Cell
  • CKDChronic Kidney Disease
  • DRTDecellularization- Recellularization Technology
  • ECMExtracellularMatrix
  • ESC Embryonic Stem Cell
  • ESRD End-Stage RenalDisease
  • HafscHuman Amniotic Fluid-Derived Stem Cells
  • IPSC Induced Pluripotent Stem Cells
  • MSC Mesenchymal Stem Cell
  • RADRenalTubuleAssisted Device
  • RMRegenerativeMedicine

ASJC Scopus subject areas

  • Urology

Cite this

Regeneration and bioengineering of the kidney : Current status and future challenges. / Salvatori, Marcus; Peloso, Andrea; Katari, Ravi; Orlando, Giuseppe.

In: Current Urology Reports, Vol. 15, No. 1, 379, 01.2014.

Research output: Contribution to journalArticle

Salvatori, Marcus ; Peloso, Andrea ; Katari, Ravi ; Orlando, Giuseppe. / Regeneration and bioengineering of the kidney : Current status and future challenges. In: Current Urology Reports. 2014 ; Vol. 15, No. 1.
@article{73071e589244489592ec30777685fdcb,
title = "Regeneration and bioengineering of the kidney: Current status and future challenges",
abstract = "The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.",
keywords = "ARFAcuteRenalFailure, BAKBio-ArtificialKidney, BMDCBone Marrow-Derived Stem Cell, CKDChronic Kidney Disease, DRTDecellularization- Recellularization Technology, ECMExtracellularMatrix, ESC Embryonic Stem Cell, ESRD End-Stage RenalDisease, HafscHuman Amniotic Fluid-Derived Stem Cells, IPSC Induced Pluripotent Stem Cells, MSC Mesenchymal Stem Cell, RADRenalTubuleAssisted Device, RMRegenerativeMedicine",
author = "Marcus Salvatori and Andrea Peloso and Ravi Katari and Giuseppe Orlando",
year = "2014",
month = "1",
doi = "10.1007/s11934-013-0379-9",
language = "English",
volume = "15",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Regeneration and bioengineering of the kidney

T2 - Current status and future challenges

AU - Salvatori, Marcus

AU - Peloso, Andrea

AU - Katari, Ravi

AU - Orlando, Giuseppe

PY - 2014/1

Y1 - 2014/1

N2 - The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.

AB - The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.

KW - ARFAcuteRenalFailure

KW - BAKBio-ArtificialKidney

KW - BMDCBone Marrow-Derived Stem Cell

KW - CKDChronic Kidney Disease

KW - DRTDecellularization- Recellularization Technology

KW - ECMExtracellularMatrix

KW - ESC Embryonic Stem Cell

KW - ESRD End-Stage RenalDisease

KW - HafscHuman Amniotic Fluid-Derived Stem Cells

KW - IPSC Induced Pluripotent Stem Cells

KW - MSC Mesenchymal Stem Cell

KW - RADRenalTubuleAssisted Device

KW - RMRegenerativeMedicine

UR - http://www.scopus.com/inward/record.url?scp=84890926411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890926411&partnerID=8YFLogxK

U2 - 10.1007/s11934-013-0379-9

DO - 10.1007/s11934-013-0379-9

M3 - Article

C2 - 24375058

AN - SCOPUS:84890926411

VL - 15

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 1

M1 - 379

ER -